Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating bupropion extended-release and escitalopram in adults with major depressive disorder has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Bupropion hydrochloride extended-release tablet (bupropion hydrochloride extended-release)
• Escitalopram oxalate capsule (escitalopram)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED | Results posted: 2019-02-18